The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke
Open accessAbstract
Importance: Recanalization of intracranial thrombus is associated with improved clinical outcome in patients with acute ischemic stroke. The association of intravenous alteplase treatment and thrombus characteristics with recanalization over time is important for stroke triage and future trial design. Objective: To examine recanalization over time across a range of intracranial thrombus occlusion sites and clinical and imaging characteristics in patients with ischemic stroke treated with intravenous alteplase or not treated with alteplase. Design, Setting, and Participants: Multicenter prospective cohort study of 575 patients from 12 centers (in Canada, Spain, South Korea, the Czech Republic, and Turkey) with acute ischemic stroke and intracranial arterial occlusion demonstrated on computed tomographic angiography (CTA). Exposures: Demographics, clinical characteristics, time from alteplase to recanalization, and intracranial thrombus characteristics (location and permeability) defined on CTA. Main Outcomes and Measures: Recanalization on repeat CTA or on first angiographic acquisition of affected intracranial circulation obtained within 6 hours of baseline CTA, defined using the revised arterial occlusion scale (rAOL) (scores from 0 [primary occlusive lesion remains the same] to 3 [complete revascularization of primary occlusion]). Results: Among 575 patients (median age, 72 years [IQR, 63-80]; 51.5% men; median time from patient last known well to baseline CTA of 114 minutes [IQR, 74-180]), 275 patients (47.8%) received intravenous alteplase only, 195 (33.9%) received intravenous alteplase plus endovascular thrombectomy, 48 (8.3%) received endovascular thrombectomy alone, and 57 (9.9%) received conservative treatment. Median time from baseline CTA to recanalization assessment was 158 minutes (IQR, 79-268); median time from intravenous alteplase start to recanalization assessment was 132.5 minutes (IQR, 62-238). Successful recanalization occurred at an unadjusted rate of 27.3% (157/575) overall, including in 30.4% (143/470) of patients who received intravenous alteplase and 13.3% (14/105) who did not (difference, 17.1% [95% CI, 10.2%-25.8%]). Among patients receiving alteplase, the following factors were associated with recanalization: time from treatment start to recanalization assessment (OR, 1.28 for every 30-minute increase in time [95% CI, 1.18-1.38]), more distal thrombus location, eg, distal M1 middle cerebral artery (39/84 [46.4%]) vs internal carotid artery (10/92 [10.9%]) (OR, 5.61 [95% CI, 2.38-13.26]), and higher residual flow (thrombus permeability) grade, eg, hairline streak (30/45 [66.7%]) vs none (91/377 [24.1%]) (OR, 7.03 [95% CI, 3.32-14.87]). Conclusions and Relevance: In patients with acute ischemic stroke, more distal thrombus location, greater thrombus permeability, and longer time to recanalization assessment were associated with recanalization of arterial occlusion after administration of intravenous alteplase; among patients who did not receive alteplase, rates of arterial recanalization were low. These findings may help inform treatment and triage decisions in patients with acute ischemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Goyal, M., Menon, B. K., van Zwam, W. H., Dippel, D. W. J., Mitchell, P. J., Demchuk, A. M., Dávalos, A., Majoie, C. B. L. M., van der Lugt, A., de Miquel, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00163-x · Cited by 7,815
Self-citationThrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
Goyal, M., Demchuk, A. M., Menon, B. K., Eesa, M., Rempel, J. L., Thornton, J., Roy, D., Jovin, T. G., Willinsky, R. A., Sapkota, B. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414905 · Cited by 6,083
Self-citationBenardete, E. A., & Nair, A. K. (2015) · Cerebrovascular Diseases Extra · doi:10.1159/000370060 · Cited by 2,546
Saver, J. L. (2006) · Stroke · doi:10.1161/01.str.0000196957.55928.ab · Cited by 2,181
Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
Saver, J. L., Goyal, M., van der Lugt, A., Menon, B. K., Majoie, C. B. L. M., Dippel, D. W., Campbell, B. C., Nogueira, R. G., Demchuk, A. M., Tomasello, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.13647 · Cited by 2,180
Self-citationAoki, J., Kimura, K., Shibazaki, K., & Sakamoto, Y. (2013) · Cerebrovascular Diseases Extra · doi:10.1159/000348552 · Cited by 1,929
Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
Alexandrov, A. V., Molina, C. A., Grotta, J. C., Garami, Z., Ford, S. R., Alvarez-Sabin, J., Montaner, J., Saqqur, M., Demchuk, A. M., Moyé, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041175 · Cited by 1,046
Self-citationRecombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
Campbell, B. C. V., Mitchell, P. J., Churilov, L., Yassi, N., Kleinig, T. J., Dowling, R. J., Yan, B., Bush, S. J., Dewey, H. M., Thijs, V., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716405 · Cited by 885
Saver, J. L., Fonarow, G. C., Smith, E. E., Reeves, M. J., Grau-Sepulveda, M. V., Pan, W., Olson, D. M., Hernandez, A. F., Peterson, E. D., & Schwamm, L. H. (2013) · JAMA · doi:10.1001/jama.2013.6959 · Cited by 870
Self-citationBhatia, R., Hill, M. D., Shobha, N., Menon, B., Bal, S., Kochar, P., Watson, T., Goyal, M., & Demchuk, A. M. (2010) · Stroke · doi:10.1161/strokeaha.110.592535 · Cited by 725
Self-citationMultiphase CT Angiography: A New Tool for the Imaging Triage of Patients with Acute Ischemic Stroke
Menon, B. K., d’Esterre, C. D., Qazi, E. M., Almekhlafi, M., Hahn, L., Demchuk, A. M., & Goyal, M. (2015) · Radiology · doi:10.1148/radiol.15142256 · Cited by 699
Self-citation(2006) · Annals of Neurology · doi:10.1002/(issn)1531-8249 · Cited by 513
Puetz, V., Dzialowski, I., Hill, M. D., Subramaniam, S., Sylaja, P. N., Krol, A., O'Reilly, C., Hudon, M. E., Hu, W. Y., Coutts, S. B., et al. (2008) · International Journal of Stroke · doi:10.1111/j.1747-4949.2008.00221.x · Cited by 304
Self-citationSeners, P., Turc, G., Maïer, B., Mas, J.-L., Oppenheim, C., & Baron, J.-C. (2016) · Stroke · doi:10.1161/strokeaha.116.014181 · Cited by 290
Alexandrov, A. V., Burgin, W. S., Demchuk, A. M., El-Mitwalli, A., & Grotta, J. C. (2001) · Circulation · doi:10.1161/01.cir.103.24.2897 · Cited by 271
Self-citationMolina, C. A., Montaner, J., Abilleira, S., Ibarra, B., Romero, F., Arenillas, J. F., & Alvarez-Sabín, J. (2001) · Stroke · doi:10.1161/01.str.32.5.1079 · Cited by 266
Khatri, P., Neff, J., Broderick, J. P., Khoury, J. C., Carrozzella, J., & Tomsick, T. (2005) · Stroke · doi:10.1161/01.str.0000185698.45720.58 · Cited by 235
Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications
Zangerle, A., Kiechl, S., Spiegel, M., Furtner, M., Knoflach, M., Werner, P., Mair, A., Wille, G., Schmidauer, C., Gautsch, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000250341.38014.d2 · Cited by 215
Temporal Profile of Recanalization After Intravenous Tissue Plasminogen Activator
Ribó, M., Álvarez‐Sabín, J., Montaner, J., Romero, F. J., Delgado, P., Rubiera, M., Delgado‐Mederos, R., & Molina, C. A. (2006) · Stroke · doi:10.1161/01.str.0000206443.96112.d9 · Cited by 130
Barreto, A. D., Alexandrov, A. V., Lyden, P., Lee, J. D., Martin‐Schild, S., Shen, L. F., Wu, T., Sisson, A., Pandurengan, R. K., Chen, Z., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.625574 · Cited by 128
Self-citationKim, Y. D., Nam, H. S., Kim, S. H., Kim, E. Y., Song, D., Kwon, I. W., Yang, S.-H., Lee, K., Yoo, J., Lee, H. S., et al. (2015) · Stroke · doi:10.1161/strokeaha.114.008247 · Cited by 88
What constitutes the M1 segment of the middle cerebral artery?
Goyal, M., Menon, B. K., Krings, T., Patil, S., Qazi, E. M., McTaggart, R., Almekhlafi, M., Jehan, R., Saver, J. L., & Jayaraman, M. V. (2016) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2015-012191 · Cited by 82
Self-citationCoagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke
Huang, X., Moreton, F. C., Kalladka, D., Cheripelli, B. K., Macisaac, R. L., Tait, R. C., & Muir, K. W. (2015) · Stroke · doi:10.1161/strokeaha.115.011290 · Cited by 74
Cited by
Campbell, B. C. V., De Silva, D. A., Macleod, M. R., Coutts, S. B., Schwamm, L. H., Davis, S. M., & Donnan, G. A. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0118-8 · Cited by 1,750
Self-citationSaver, J. L., Chapot, R., Agid, R., Hassan, A. E., Jadhav, A. P., Liebeskind, D. S., Lobotesis, K., Meila, D., Meyer, L., Raphaeli, G., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.028956 · Cited by 456
Endovascular Treatment of Acute Ischemic Stroke
Jahan, R., & Saver, J. L. (2022) · Stroke · doi:10.1016/b978-0-323-69424-7.00067-3 · Cited by 396
Thrombolysis for acute ischaemic stroke: current status and future perspectives
Tsivgoulis, G., Katsanos, A. H., Sandset, E. C., Turc, G., Nguyen, T. N., Bivard, A., Fischer, U., & Khatri, P. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00519-1 · Cited by 372
Metadata
- Authors
- Menon, B. K., Al-Ajlan, F. S., Najm, M., Puig, J., Castellanos, M., Dowlatshahi, D., Calleja, A., Sohn, S.-I., Ahn, S. H., Poppe, A., Mikulik, R., Asdaghi, N., Field, T. S., Jin, A., Asil, T., Boulanger, J.-M., Smith, E. E., Coutts, S. B., Barber, P. A., Bal, S., Subramanian, S., Mishra, S., Trivedi, A., Dey, S., Eesa, M., Sajobi, T., Goyal, M., Hill, M. D., Demchuk, A. M., & for the INTERRSeCT Study Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-09-11
- Volume
- 320
- Issue
- 10
- Pages
- 1017
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2890910536
- Cited by
- 284
- References
- 26
- FWCI
- 17.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.